Terms: = Lymphoma AND SDHB, PGL4, 6390, ENSG00000117118, SDH1, SDHIP, SDH, IP AND Diagnosis
33 results:
1. MYCT1 inhibits hematopoiesis in diffuse large B-cell lymphoma by suppressing RUNX1 transcription.
Liang Y; Wei X; Yue PJ; Zhang HC; Li ZN; Wang XX; Sun YY; Fu WN
Cell Mol Biol Lett; 2024 Jan; 29(1):5. PubMed ID: 38172714
[TBL] [Abstract] [Full Text] [Related]
2. PHi-RACE: PGIMER in-house rapid & cost effective classifier for the detection of
Gupta DG; Varma N; Kumar A; Naseem S; Sachdeva MUS; Binota J; Bose P; Gupta M; Sonam P; Rana P; Malhotra P; Khadwal A; Trehan A; Varma S
Leuk Lymphoma; 2022 Mar; 63(3):633-643. PubMed ID: 34783280
[TBL] [Abstract] [Full Text] [Related]
3. Immunophenotypic expression and immunomodulation in minimal residual disease analysis of pediatric B acute lymphoblastic leukemia by high sensitive flow cytometry.
Arumugam JR; Bommannan K; Radhakrishnan V; Sagar TG; Sundersingh S
Leuk Lymphoma; 2022 Mar; 63(3):644-652. PubMed ID: 34727819
[TBL] [Abstract] [Full Text] [Related]
4. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in the Childhood Cancer Survivor Study.
Kim J; Gianferante M; Karyadi DM; Hartley SW; Frone MN; Luo W; Robison LL; Armstrong GT; Bhatia S; Dean M; Yeager M; Zhu B; Song L; Sampson JN; Yasui Y; Leisenring WM; Brodie SA; de Andrade KC; Fortes FP; Goldstein AM; Khincha PP; Machiela MJ; McMaster ML; Nickerson ML; Oba L; Pemov A; Pinheiro M; Rotunno M; Santiago K; Wegman-Ostrosky T; Diver WR; Teras L; Freedman ND; Hicks BD; Zhu B; Wang M; Jones K; Hutchinson AA; Dagnall C; Savage SA; Tucker MA; Chanock SJ; Morton LM; Stewart DR; Mirabello L
JNCI Cancer Spectr; 2021 Apr; 5(2):. PubMed ID: 34308104
[TBL] [Abstract] [Full Text] [Related]
5. Influence of loneliness and social isolation on the diagnosis and treatment of Japanese patients with advanced lung cancer: a prospective cohort study.
Takemura T; Kataoka Y; Shirakawa C; Okazaki K; Sakurai A; Imakita T; Ikegaki S; Matsumoto H; Saito E; Takata H; Kaku S; Wada N; Shinomiya M; Otoshi T; Shimada M; Nikaido J; Iki R; Hirano K; Hirai T; Endo K; Hirabayashi M; Naganuma T
Ann Palliat Med; 2021 Jun; 10(6):6236-6246. PubMed ID: 34118842
[TBL] [Abstract] [Full Text] [Related]
6. Machine Learning Approach for Intraocular Disease Prediction Based on Aqueous Humor Immune Mediator Profiles.
Nezu N; Usui Y; Saito A; Shimizu H; Asakage M; Yamakawa N; Tsubota K; Wakabayashi Y; Narimatsu A; Umazume K; Maruyama K; Sugimoto M; Kuroda M; Goto H
Ophthalmology; 2021 Aug; 128(8):1197-1208. PubMed ID: 33484732
[TBL] [Abstract] [Full Text] [Related]
7. Apoptotic regulator BCL-2 blockade as a potential therapy in classical Hodgkin lymphoma.
Gamboa-Cedeño AM; Díaz M; Cristaldo N; Otero V; Schutz N; Fantl D; Cugliari S; Zerga M; Rojas-Bilbao E; Jauk F; García Rivello H; Nuñez M; Ranuncolo SM
Life Sci; 2021 Mar; 268():118979. PubMed ID: 33421528
[TBL] [Abstract] [Full Text] [Related]
8. Bright CD38 Expression by Flow Cytometric Analysis Is a Biomarker for Double/Triple Hit lymphomas with a Moderate Sensitivity and High Specificity.
Alsuwaidan A; Pirruccello E; Jaso J; Koduru P; Garcia R; Krueger J; Doucet M; Chaudhry R; Fuda F; Chen W
Cytometry B Clin Cytom; 2019 Sep; 96(5):368-374. PubMed ID: 30734478
[TBL] [Abstract] [Full Text] [Related]
9. Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including sdh-deficient ones, to respond to alkylating agents.
Ricci R; Martini M; Ravegnini G; Cenci T; Milione M; Lanza P; Pierconti F; Santini D; Angelini S; Biondi A; Rosa F; Alfieri S; Clemente G; Persiani R; Cassano A; Pantaleo MA; Larocca LM
Clin Epigenetics; 2019 Jan; 11(1):2. PubMed ID: 30616628
[TBL] [Abstract] [Full Text] [Related]
10. Profiles of serum cytokines and their clinical implications in patients with peripheral T-cell lymphoma.
Yi JH; Ryu KJ; Ko YH; Kim WS; Kim SJ
Cytokine; 2019 Jan; 113():371-379. PubMed ID: 30327172
[TBL] [Abstract] [Full Text] [Related]
11. EGFR signaling defines Mcl⁻1 survival dependency in neuroblastoma.
Nalluri S; Peirce SK; Tanos R; Abdella HA; Karmali D; Hogarty MD; Goldsmith KC
Cancer Biol Ther; 2015; 16(2):276-86. PubMed ID: 25756510
[TBL] [Abstract] [Full Text] [Related]
12. Brain metastases in patients with ALK+ non-small cell lung cancer: clinical symptoms, treatment patterns and economic burden.
Guérin A; Sasane M; Zhang J; Culver KW; Dea K; Nitulescu R; Wu EQ
J Med Econ; 2015 Apr; 18(4):312-22. PubMed ID: 25565443
[TBL] [Abstract] [Full Text] [Related]
13. [Diagnostic value of brain biopsy in intravascular large B-cell lymphoma mimicking progressive multifocal leukoencephalopathy: case report].
Takamine Y; Ikumi N; Onoe H; Hayase M; Nagasawa Y; Sakagami M; Sugiyama K; Nakagawa S; Uchino Y; Takahashi H; Hirabayashi Y; Nozaki T; Miura K; Inomata H; Iriyama N; Shiraiwa H; Kobayashi S; Kitamura N; Hatta Y; Matsukawa Y; Takei M
Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(2):111-5. PubMed ID: 24835139
[TBL] [Abstract] [Full Text] [Related]
14. Elevated serum monoclonal and polyclonal free light chains and interferon inducible protein-10 predicts inferior prognosis in untreated diffuse large B-cell lymphoma.
Witzig TE; Maurer MJ; Stenson MJ; Allmer C; Macon W; Link B; Katzmann JA; Gupta M
Am J Hematol; 2014 Apr; 89(4):417-22. PubMed ID: 24382707
[TBL] [Abstract] [Full Text] [Related]
15. Serum levels of cytokines and biomarkers for inflammation and immune activation, and HIV-associated non-Hodgkin B-cell lymphoma risk.
Vendrame E; Hussain SK; Breen EC; Magpantay LI; Widney DP; Jacobson LP; Variakojis D; Knowlton ER; Bream JH; Ambinder RF; Detels R; Martínez-Maza O
Cancer Epidemiol Biomarkers Prev; 2014 Feb; 23(2):343-9. PubMed ID: 24220912
[TBL] [Abstract] [Full Text] [Related]
16. IP-10/CXCL10 and MIG/CXCL9 as novel markers for the diagnosis of lymphoma-associated hemophagocytic syndrome.
Maruoka H; Inoue D; Takiuchi Y; Nagano S; Arima H; Tabata S; Matsushita A; Ishikawa T; Oita T; Takahashi T
Ann Hematol; 2014 Mar; 93(3):393-401. PubMed ID: 23975214
[TBL] [Abstract] [Full Text] [Related]
17. Evaluation of circulating concentrations of CXCL1 (Gro-α), CXCL10 (IP-10) and CXCL12 (SDF-1) in ALL patients prior and post bone marrow transplantation.
Khandany BK; Hassanshahi G; Khorramdelazad H; Balali Z; Shamsizadeh A; Arababadi MK; Ostadebrahimi H; Fatehi A; Rezazadeh M; Ahmadi Z; Karimabad MN
Pathol Res Pract; 2012 Oct; 208(10):615-9. PubMed ID: 22975476
[TBL] [Abstract] [Full Text] [Related]
18. Increased T-cell activation and Th1 cytokine concentrations prior to the diagnosis of B-cell lymphoma in HIV infected patients.
Ouedraogo DE; Makinson A; Kuster N; Nagot N; Rubbo PA; Bollore K; Foulongne V; Cartron G; Olive D; Reynes J; Vendrell JP; Tuaillon E
J Clin Immunol; 2013 Jan; 33(1):22-9. PubMed ID: 22914896
[TBL] [Abstract] [Full Text] [Related]
19. Low absolute lymphocyte count and addition of rituximab confer high risk for interstitial pneumonia in patients with diffuse large B-cell lymphoma.
Huang YC; Liu CJ; Liu CY; Pai JT; Hong YC; Teng HW; Hsiao LT; Chao TC; Gau JP; Liu JH; Hsu HC; Chiou TJ; Chen PM; Yu YB; Tzeng CH
Ann Hematol; 2011 Oct; 90(10):1145-51. PubMed ID: 21647583
[TBL] [Abstract] [Full Text] [Related]
20. Cytokine signatures of transformed B cells with distinct Epstein-Barr virus latencies as a potential diagnostic tool for B cell lymphoma.
Miyauchi K; Urano E; Yoshiyama H; Komano J
Cancer Sci; 2011 Jun; 102(6):1236-41. PubMed ID: 21392167
[TBL] [Abstract] [Full Text] [Related]
[Next]
